A retrospective study to determine clinical and laboratory parameters associated with vaccine response and effect of BTKi interruption after administration of booster dose
Latest Information Update: 11 Oct 2022
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 11 Oct 2022 New trial record
- 01 Oct 2022 Results published in the Clinical Lymphoma, Myeloma & Leukemia